Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Drugs|June 14, 2000
Diabetic dyslipidaemia: current treatment recommendationsJ D Best, D N O'Neal
Australian Family Physician|September 1, 1993
Diabetes and vascular diseaseJ D Best, D N O'Neal
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|September 30, 1999
The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapyD N O'Neal, F L Hew, J D Best, et al.
Atherosclerosis|April 17, 1998
Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjectsD N O'Neal, J Lewicki, M Z Ansari, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 24, 1997
Low-density lipoprotein size, high-density lipoprotein concentration, and endothelial dysfunction in non-insulin-dependent diabetesS F O'Brien, G F Watts, D A Playford, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 31, 1998
Gemfibrozil treatment increases low-density lipoprotein particle size in Type 2 diabetes mellitus but does not alter in vitro oxidizabilityD N O'Neal, R C O'Brien, K L Timmins, et al.
Australian Family Physician|October 1, 1984
Insulin and oral hypoglycaemicsJ D Best
Expert Opinion on Investigational Drugs|January 5, 2002
Novel agents for managing dyslipidaemiaJ D Best, A J Jenkins
Pageof 11